A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- NA
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- NA
Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Serplulimab Combined With CCRT for LS-SCLC.
- Status
- RECRUITING
- Phase
- PHASE2
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1